Internal Medicine, Bariatric Medicine · Tampa, FL
NPI
1841273943
Since 2005
Specialty
Internal Medicine, Bariatric Medicine
Code 207RB0002X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
800 W Dr Martin Luther King Jr Blvd Ste 4
Tampa, FL, 33603
Phone (813) 971-8700
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
15,815 services
Medicare patients, 2024
41
Average age 57
Drug cost, 2024
$1.7M
1,386 prescriptions
Company payments, 2025
$610
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jawan C Ayer was code J2405 (injection, ondansetron hydrochloride, per 1 mg), 3,428 times for 11 patients. In total Jawan C Ayer billed 15,815 services in 29 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 3,428 | 11 | $0.07 | $253 |
| 96361 Intravenous Infusion, Hydration | Office | 3,025 | 12 | $9.32 | $28K |
| 96375 Injection Administration | Office | 1,771 | 11 | $11.52 | $20K |
| 96367 Intravenous Infusion, Hydration | Office | 1,259 | 13 | $21.18 | $27K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 1,082 | 12 | $0.64 | $696 |
| 99213 Office E&M - Established | Office | 556 | 14 | $69.28 | $39K |
| 96365 Intravenous Infusion, Hydration | Office | 542 | 12 | $46.73 | $25K |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 498 | 12 | $2.08 | $1,034 |
| 99214 Office E&M - Established | Office | 183 | 37 | $88.46 | $16K |
By year: 2022 $280K for 23,895 services; 2023 $278K for 24,417 services; 2024 $166K for 15,815 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jawan C Ayer prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 144 prescriptions and refills. In total Jawan C Ayer wrote 1,386 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 144 | 144 | 19 | $3,838 |
| Eliquis Apixaban | 106 | 112 | 13 | $62K |
| Morphine Sulfate Er Morphine Sulfate | 96 | 96 | 11 | $2,849 |
| Hydromorphone Hcl Generic | 78 | 78 | Under 11 | $964 |
| Ozempic Semaglutide | 62 | 66 | 13 | $59K |
| Hydroxyurea Generic | 56 | 94 | 20 | $1,580 |
| Promethazine Hcl Generic | 45 | 45 | Under 11 | $689 |
| Xarelto Rivaroxaban | 37 | 37 | Under 11 | $20K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 36 | 52 | Under 11 | $222 |
| Lisinopril Generic | 35 | 60 | Under 11 | $90.03 |
| Gabapentin Generic | 33 | 33 | Under 11 | $305 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 31 | 31 | Under 11 | $345 |
| Bupropion Hcl Sr Bupropion Hcl | 29 | 41 | Under 11 | $340 |
| Oxbryta Voxelotor | 25 | 27 | Under 11 | $272K |
| Topiramate Generic | 25 | 25 | Under 11 | $41.94 |
Brand drugs: 391 claims; generic drugs: 995 claims; opioid claims: 391.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jawan C Ayer $610 ($610 in general payments such as food, travel and fees) from 11 companies. The largest payer was Agios Pharmaceuticals, Inc. with $208.
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. AGIO | 5 | $208 |
| Novo Nordisk Inc NVO | 1 | $116 |
| Incyte Corporation INCY | 3 | $63.53 |
| Genetix Biotherapeutics Inc | 1 | $41.54 |
| Lilly USA, LLC LLY | 2 | $38.65 |
| BeiGene USA, Inc. ONC | 1 | $34.82 |
| Recordati_rare_diseases_inc. | 1 | $25.37 |
| Emmaus Medical, Inc. | 1 | $24.88 |
| Pfizer Inc. PFE | 1 | $22.19 |
| Shield Therapeutics Inc STX.L | 1 | $21.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.